References
- Albelda SM, Muller WA, Buck CA , Newman P J (1991). Molecular and cellular properties of PECAM-1 (endoCAM/ CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol, 114, 1059-68. https://doi.org/10.1083/jcb.114.5.1059
- Appelhoff R J, Tian Y-M, Raval R R, et al (2004). Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem, 279, 38458-65. https://doi.org/10.1074/jbc.M406026200
- Brahimi-Horn MC, Chiche J, Pouyssegur J (2007). Hypoxia and cancer. Int J Mol Med, 85, 1301-7. https://doi.org/10.1007/s00109-007-0281-3
- Brown JM (2002). Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther, 1, 453-8. https://doi.org/10.4161/cbt.1.5.157
- Bussolino F, Mantovani A , Persico G (1997). Molecular mechanisms of blood vessel formation. Trends Biochem Sci, 22, 251-6. https://doi.org/10.1016/S0968-0004(97)01074-8
- Choi WW, Lewis MM, Lawson D, et al (2005). Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGFfamily gene expression. Modern Pathol, 18, 143-52. https://doi.org/10.1038/modpathol.3800253
- Cote ML, Liu M, Bonassi S, et al (2012). Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer, 48, 1957-68. https://doi.org/10.1016/j.ejca.2012.01.038
- Couvelard A, Deschamps L, Rebours V, et al (2008). Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumors. Clin Cancer Res, 14, 6634-9. https://doi.org/10.1158/1078-0432.CCR-07-5258
- D'Angelo G, Duplan E, Boyer N, et al (2003). Hypoxia up-regulates prolyl hydroxylase activity by a feedback mechanism that limits HIF-1 response during reoxygenation. J Biol Chem, 278, 38183-7. https://doi.org/10.1074/jbc.M302244200
- Dejana E (2004). Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Bio, 5, 261-70. https://doi.org/10.1038/nrm1357
- DeLisser H M, Christofidou-Solomidou M, Strieter R M, et al (1997). Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol, 151, 671.
-
Ema M, Taya S, Yokotani N, et al (1997). A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor
$1{\alpha}$ regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA, 94, 4273-8. https://doi.org/10.1073/pnas.94.9.4273 - Fields AC, Cotsonis G, Sexton D, et al (2004). Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome. Modern Pathol, 17, 1378-85. https://doi.org/10.1038/modpathol.3800203
- Fu P, Du F, Chen W, et al (2014). Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1alpha downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines. Oncol Rep, 31, 2561-8.
- Le Q-T, Chen E, Salim A, et al (2006). An Evaluation of Tumor Oxygenation and Gene Expression in Patients with Early Stage Non-Small Cell Lung Cancers. Clin Cancer Res, 12, 1507-14. https://doi.org/10.1158/1078-0432.CCR-05-2049
- Li C, Lu HJ, Na FF, et al (2013a). Prognostic role of hypoxic inducible factor expression in non-small cell lung cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 3607-12. https://doi.org/10.7314/APJCP.2013.14.6.3607
- Li DW, Dong P, Wang F, et al (2013b). Hypoxia induced multidrug resistance of laryngeal cancer cells via hypoxiainducible factor-1alpha. Asian Pac J Cancer Prev, 14, 4853-8. https://doi.org/10.7314/APJCP.2013.14.8.4853
-
Li QF, Wang XR, Yang YW , Lin H (2006). Hypoxia upregulates hypoxia inducible factor (HIF)-
$3{\alpha}$ expression in lung epithelial cells: characterization and comparison with HIF-$1{\alpha}$ . Exp Cell Res, 16, 548-58. https://doi.org/10.1038/sj.cr.7310072 - Ma CH, Jiang R, Li JD, et al (2014). Experimental study on residual tumor angiogenesis after cryoablation. Asian Pac J Cancer Prev, 15, 2491-4. https://doi.org/10.7314/APJCP.2014.15.6.2491
- Maxwell P, Pugh C , Ratcliffe P (1993). Inducible operation of the erythropoietin 3'enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci USA, 90, 2423-7. https://doi.org/10.1073/pnas.90.6.2423
- Min J H, Yang H, Ivan M, et al (2002). Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science, 296, 1886-9. https://doi.org/10.1126/science.1073440
- Muller WA (1995). The role of PECAM-1 (CD31) in leukocyte emigration: studies in vitro and in vivo. J Leukocyte Biol, 57, 523-8.
- Nishii K, Nakaseko C, Jiang M, et al (2013). The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinasetype plasminogen activator receptor (uPAR)-mediated adhesion of immature hematological cells. J Biol Chem, 288, 11877-86. https://doi.org/10.1074/jbc.M112.442491
- Pouyssegur J, Dayan F , Mazure N M (2006). Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature, 441, 437-43. https://doi.org/10.1038/nature04871
- Raval RR, Lau KW, Tran MG, et al (2005). Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol, 25, 5675-86. https://doi.org/10.1128/MCB.25.13.5675-5686.2005
- Reedquist KA, Ross E, Koop EA, et al (2000). The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J Cell Biol, 148, 1151-8. https://doi.org/10.1083/jcb.148.6.1151
- Samudio I, Fiegl M , Andreeff M (2009). Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. Cancer Res, 69, 2163-6. https://doi.org/10.1158/0008-5472.CAN-08-3722
- Schiller JH, Harrington D, Belani CP, et al (2002). Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. New Engl J Med, 346, 92-8. https://doi.org/10.1056/NEJMoa011954
- Semenza G L (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 3, 721-32. https://doi.org/10.1038/nrc1187
- Shijubo N, Uede T, Kon S, et al (1999). Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. Am J Resp Crit Care, 160, 1269-73. https://doi.org/10.1164/ajrccm.160.4.9807094
- Stacker SA, Achen MG, Jussila L, et al (2002). Metastasis: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer, 2, 573-83. https://doi.org/10.1038/nrc863
- Swinson DE, Jones JL, Richardson D, et al (2003). Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-smallcell lung cancer. J Clin Oncol, 21, 473-82. https://doi.org/10.1200/JCO.2003.11.132
- Vaupel P (2008). Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. Oncologist, 13, 21-6.
- Weidner N, Folkman J, Pozza F, et al (1992). Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer I, 84, 1875-87. https://doi.org/10.1093/jnci/84.24.1875
- Zhang YC, Jiang G, Gao H, et al (2014). Influence of ionizing radiation on ovarian carcinoma SKOV- 3 xenografts in nude mice under hypoxic conditions. Asian Pac J Cancer Prev, 15, 2353-8. https://doi.org/10.7314/APJCP.2014.15.5.2353